Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
PMBCT-01 by PeproMene Bio for Marginal Zone B-cell Lymphoma: Likelihood of Approval
PMBCT-01 is under clinical development by PeproMene Bio and currently in Phase I for Marginal Zone B-cell Lymphoma. According to...
PMBCT-01 by PeproMene Bio for Primary Mediastinal B-Cell Lymphoma: Likelihood of Approval
PMBCT-01 is under clinical development by PeproMene Bio and currently in Phase I for Primary Mediastinal B-Cell Lymphoma. According to...
PMBCT-01 by PeproMene Bio for B-Cell Non-Hodgkin Lymphoma: Likelihood of Approval
PMBCT-01 is under clinical development by PeproMene Bio and currently in Phase I for B-Cell Non-Hodgkin Lymphoma. According to GlobalData,...
PMBCT-01 by PeproMene Bio for Follicular Lymphoma: Likelihood of Approval
PMBCT-01 is under clinical development by PeproMene Bio and currently in Phase I for Follicular Lymphoma. According to GlobalData, Phase...